Body may be able to 'coach' transplanted stem cells to differentiate appropriately
Pluripotent stem cells are nature's double-edged sword. Because they can develop into a dizzying variety of cell types and tissues, they are a potentially invaluable therapeutic resource. However, that same developmental flexibility can lead to dangerous tumors called teratomas if the stem cells begin to differentiate out of control in the body.
To prevent this outcome, researchers must first give the cells a not-so-subtle shove toward their final developmental fate before transplanting them into laboratory animals or humans. But exactly how to do so can vary widely among laboratories. Now researchers at the Stanford University School of Medicine have used an experiment in mice to hit upon a way to possibly skip this fiddly step by instead relying mostly on signals within the body to keep the stem cells in line.
"Before we can use these cells, we have to differentiate, or 'coach,' them down a specific developmental pathway," said Michael Longaker, MD, the Deane P. and Louise Mitchell Professor in the School of Medicine. "But there's always a question as to exactly how to do that, and how many developmental doors we have to close before we can use the cells. In this study, we found that, with appropriate environmental cues, we could let the body do the work."
Allowing the body to direct differentiation could speed the U.S. Food and Drug Administration's approval of using such pluripotent stem cells, Longaker believes, by eliminating the extended periods of laboratory manipulation required during the forced differentiation of the cells.
Longaker, who co-directs Stanford's Institute for Stem Cell Biology and Regenerative Medicine, is the senior author of the research, which will be published online Nov. 19 in the Proceedings of the National Academy of Sciences. Postdoctoral scholars Benjamin Levi, MD, and Jeong Hyun, MD, and research assistant Daniel Montoro are co-first authors of the work. Longaker is also a member of the Stanford Cancer Institute.
"Once we identify the key proteins and signals coaching the tissue within the body, we can try to mimic them when we use the stem cells," said Longaker. "Just as the shape of water is determined by its container, cells respond to external cues. For example, in the future, if you want to replace a failing liver, you could put the cells in a scaffold or microenvironment that strongly promotes liver cell differentiation and place the cell-seeded scaffold into the liver to let them differentiate in the optimal macroenvironment."
In Longaker's case, the researchers were interested not in the liver, but in bone formation. Longaker himself is a pediatric plastic and reconstructive surgeon who specializes in craniofacial malformations. "Imagine being able to treat children and adults who require craniofacial skeletal reconstruction, not with surgery, but with stem cells," he said.
The researchers removed a 4 millimeter circle of bone from the skulls of anesthetized laboratory mice—a defect just large enough to stymie the natural healing properties of the bone's endogenous stem cells. They then implanted in the damaged area a tiny, artificial scaffold coated with a protein called BMP-2 that they knew (from previous experiments) stimulated bone growth. Each scaffold was seeded with 1 million human stem cells. They then waited and watched for several months as the bone regrew.
"We found that the human cells formed bone and repaired the defect," said Longaker. "What's more, over time that human bone created by the stem cells was eventually replaced by mouse bone as part of the natural turnover process. So the repair was physiologically normal."
The researchers credit the regrowth to the tandem nature of a macroenvironment of bone damage and a microenvironment of scaffolding coated with a bone-growth-triggering molecule.
The researchers tested the ability of both human embryonic stem cells and human induced pluripotent stem cells, or iPS cells, to heal the defects. (iPS cells are generated in the laboratory from fully differentiated cells like those found in skin, whereas embryonic stem cells are isolated from human embryos.) They found that the iPS cells seeded onto the BMP-2-containing scaffolds healed more than 96 percent of the defect within eight weeks of transplantation. Human embryonic stem cells were similarly successful, healing 99 percent of the defect within eight weeks.
In addition to repairing the defect, the technique also produced relatively few dangerous teratomas: Two out of 42 animals in the study developed the tumors. (Both teratomas occurred in animals that had received embryonic stem cells, rather than iPS cells.) In contrast, both types of stem cells readily formed teratomas when implanted under the kidney surface of an immunodeficient animal—a standard laboratory test to confirm stem cells' pluripotent potential.
"We still have work to do to completely eliminate teratoma formation," said Longaker, "but we are highly encouraged." He speculates that combining the technique with other strategies—perhaps by including other cell types to act as chaperones to the differentiating stem cells—may eventually overcome the problem.
"I want to see how broadly applicable this technique may be," said Longaker, who speculated that it may be useful to replace damaged cartilage in joints during arthroscopy. "Cartilage doesn't heal itself, so perhaps you can add some cells that can form replacement tissue in this macroenvironment while you're already looking in the joint."
Journal reference: Proceedings of the National Academy of Sciences
Provided by Stanford University Medical Center
- Cryopreservation of induced pluripotent stem cells improved the most by one product Sep 25, 2012 | not rated yet | 0
- 'Liposuction leftovers' easily converted to IPS cells, study shows Sep 07, 2009 | not rated yet | 0
- Researchers discover key molecule for stem cell pluripotency May 27, 2011 | not rated yet | 0
- Scientists isolate the first stages of tissue production in human embryonic stem cells Jul 21, 2010 | not rated yet | 0
- Biologists find a way to lower tumor risk in stem cell therapies Jul 08, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
Medical research 12 hours ago | 5 / 5 (3) | 0 |
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research May 17, 2013 | 4 / 5 (4) | 0 |
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research May 17, 2013 | 5 / 5 (1) | 0
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research May 17, 2013 | 4 / 5 (1) | 0 |
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
12 hours ago | 4.8 / 5 (4) | 0 |
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
11 hours ago | 5 / 5 (1) | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
12 hours ago | 5 / 5 (2) | 0 |
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
16 hours ago | not rated yet | 0
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
11 hours ago | 5 / 5 (1) | 0
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
14 hours ago | not rated yet | 0